MedTrace Logo

On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours

NCT03881670 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-03-10

Study results available
· View outcomes & findings →

Summary

The current study aims to systematically investigate the diurnal variation in the optical quality of soft contact lenses on eye throughout the day. Subject reported quality of vision will also be evaluated.

Conditions

  • Hyperopia
  • Myopia

Interventions

DEVICE

Lotrafilcon B

commercially available contact lens

DEVICE

lotrafilcon B with Hydraluxe

commercially available contact lens

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-07
Primary Completion
2019-02-08
Completion
2019-02-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03881670 on ClinicalTrials.gov